Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain
Mr. De Miglio et al., Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain, HEPATOLOGY, 33(5), 2001, pp. 1110-1117
Hepatocarcinogenesis sensitivity (Hcs1,2) and resistance (Hcr1-3) loci have
been identified by linkage analysis on rat chromosomes 7 and 1, and 10, 4,
and 8, respectively. Cytogenetic studies documented deletions on chromosom
es 3 and 6 of neoplastic rat hepatocytes. Hepatocellular carcinomas (HCCs)
were produced in F1 hybrid rats between Long-Evans (LE) and Fisher 344 (F34
4) rats. Scanning of the above chromosomes for loss of heterozygosity (LOH)
showed allelic imbalance (AI) at multiple regions on chromosomes 6, 7, and
10q. Detailed deletion mapping of chromosome 10 localized a putative suppr
essor Hcr1 gene to within a 3.2-cM interval flanked by D10Rat51 and D10Rat1
21. Two other distinct regions with frequent AIs were found inside the Hcr1
locus, at marker loci including DNaseI and Mrp genes, and in a segment inc
luding 4 consecutive markers (D10Rat64, D10Rat182, D10Rat113, D10Rat216). I
n 40% of HCCs, AI was seen at the p53 locus. AI on chromosome 7 occurred at
the Hcs1 locus, where is located c-myc, which is amplified in HCCs, sugges
ting allelic gain. Most AIs occurred in poorly/moderately differentiated ca
rcinomas, and a few events were seen in well-differentiated tumors on chrom
osomes 7 and 10. These data suggest that alteration of a cluster of oncosup
pressor genes on 10q is important for HCC progression. The existence of AI
on segments of rat chromosomes 6, 7, and 10, syntenic to chromosomal segmen
ts of human HCCs where chromosomal gains or deletions occur, suggests a com
monalty of some molecular events in the pathogenesis of HCCs in rats and hu
mans. Our map provides information toward cloning putative oncosuppressor g
enes associated with this carcinoma.